Tanaporn Meejun

5PUBLICATIONS
35CO-AUTHORS
Medical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Major global burdens of diseaseEpidemiological modellingImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 09, 2026
Invasive fungal infections after Bruton tyrosine kinase inhibitor treatment: a systematic review and meta-analysis.

Karan Srisurapanont, Tanaporn Meejun, Kasama Manothummetha

|Feb 11, 2025
Improved Survival in Vascular Pythiosis With Surgery and Azithromycin, Doxycycline, and Itraconazole Therapy: A Phase II Multicenter, Open-Label, Single-Arm Trial.

Pattama Torvorapanit, Navaporn Worasilchai, Kasama Manothummetha

|Oct 08, 2024
Candidemia Following Severe COVID-19 in Hospitalised and Critical Ill Patients: A Systematic Review and Meta-Analysis.

Karan Srisurapanont, Bhoowit Lerttiendamrong, Tanaporn Meejun

|Jun 30, 2023
Attenuated immunogenicity of SARS-CoV-2 vaccines and risk factors in stem cell transplant recipients: a meta-analysis.

Tanaporn Meejun, Karan Srisurapanont, Kasama Manothummetha

|Dec 20, 2022
Immunogenicity of SARS-CoV-2 vaccines in patients with multiple myeloma: a systematic review and meta-analysis.

Nipat Chuleerarux, Kasama Manothummetha, Chatphatai Moonla

Pageof 1

Frequent Collaborators

5 joint publications

Nitipong Permpalung

4 joint publications

Nipat Chuleerarux

4 joint publications

Kasama Manothummetha

4 joint publications

Rongpong Plongla